A Cleveland-based health technology company says it has developed a system that could significantly change how patients pay for medical marijuana in states where it is legal.
EM2P2 has launched a new platform called CannaLnx that allows patients to apply existing health-benefit dollars toward medical marijuana purchases and related physician visits. The company says the system works within current insurance and wellness-benefit frameworks, offering a compliant pathway for reimbursements without requiring new insurance plans or changes to federal policy.
CannaLnx was developed as the exclusive technology partner of the American Council of Cannabis Medicine (ACCM) and serves as the digital infrastructure for ACCM’s Elevated States initiative, which is being rolled out through licensed insurance brokers ahead of open enrollment. Under the program, patients may qualify for monthly reimbursements typically ranging from $100 to $175 for medical marijuana expenses and associated healthcare visits.
Rather than creating new insurance products, CannaLnx functions as a secure, HIPAA-compliant technology layer that connects existing insurance plans and wellness benefits programs through third-party administrators (TPAs). These TPAs, which are already licensed to manage wellness benefits, bundle traditional insurance coverage with supplemental benefits that include a monthly stipend. That stipend can be used for qualified therapeutic expenses, including medical marijuana in states where it is legal.
When a patient submits a reimbursement request through the platform, CannaLnx verifies eligibility, validates the purchase and physician authorization under state law, and routes the claim to the TPA for reimbursement. Because the stipend is funded and administered by the TPA rather than the insurance carrier, the company says the structure avoids federal conflicts while remaining compliant with state regulations.
“It’s private, state-compliant, and auditable,” said EM2P2 CEO Gennaro Luce. “No taxpayer money. No federal entanglements. No creative accounting.”
The system is designed to integrate with electronic medical records and dispensary point-of-sale systems, allowing transactions to be verified and documented. According to the company, this provides transparency for employers, brokers, and dispensaries while ensuring that reimbursements are tied directly to legitimate patient purchases.
The platform is being made available in the 39 states that currently operate legal medical marijuana programs and where such benefits can be incorporated into ERISA and health-sharing plans. EM2P2 says the approach allows individuals, families, gig workers, and even large employers to offer medical marijuana benefits as part of broader wellness packages without exposing insurance carriers to federal risk.
“We don’t bend or avoid rules; we work within the rules that exist,” Luce said. “CannaLnx’s role is to ensure those rules are followed.”
Early partners include TPAs such as Detego Health, 90 Degrees, and Iron Health, along with broker groups like United Agencies that are beginning to onboard employers into the program.
The ACCM says the initiative represents a significant step toward integrating medical marijuana into mainstream healthcare benefit structures. While the platform does not create direct insurance coverage for medical marijuana, EM2P2 says it demonstrates that reimbursement for marijuana-related medical expenses can be handled lawfully, transparently, and at scale within existing healthcare frameworks.
More articles from The Marijuana Herald:
